Polypharmacy in older adults: when more medicines is a problem

Key points#

• Polypharmacy is commonly defined as regularly taking five or more medicines. It grows with age because each new condition, specialist, and hospital stay can add a drug, and a medicine once started is rarely stopped.
• More medicines can mean more risk: drug-drug and drug-disease interactions, side effects mistaken for new problems (a "prescribing cascade"), and higher chances of confusion, falls, and hospital visits.
• Some medicines carry more risk than benefit in older adults. Explicit tools such as the American Geriatrics Society Beers Criteria list drugs that are often best avoided or used with caution, as a prompt for discussion rather than an automatic ban.
• A periodic, structured medication review that includes every prescription, over-the-counter product, supplement, and eye drop is the practical way to catch duplicates, interactions, and drugs no longer serving a purpose.
• Deprescribing, the planned and supervised reduction or stopping of a medicine, is done gradually and monitored. Randomized trials and pooled analyses suggest medication burden can be reduced without increasing adverse events, though effects on hard outcomes vary.
• No one should start, change, or stop a medicine without talking to their own clinician or pharmacist.

What polypharmacy in older adults means and why it matters#

Polypharmacy in older adults means regularly taking several medicines, most often defined as five or more. It becomes a problem when the medicines start working against each other or against the person: when drugs duplicate one another, interact, cause side effects, or continue long after the reason for starting them has faded. Taking many medicines is not automatically harmful, so the real question is not how long the list is but whether each item still earns its place.

That distinction is the whole point. There is appropriate polypharmacy, where someone has several conditions that genuinely need treatment and each medicine has a clear job. And there is problematic polypharmacy, where medicines pile up, interact, or outlive their purpose. The two can look identical from the outside (a long list on a pharmacy printout). A person taking six well-chosen medicines for well-defined conditions may be far better off than a person taking four that no longer help. The number is a rough marker, not a hard line, and there is nothing magic about five.

This matters more with age. Conditions accumulate, and so do the medicines that treat them. What follows is a set of general principles for patients and families, not advice about any particular drug or dose. Nothing here should be used to start, adjust, or stop a medicine on your own.

How medication lists creep upward over time#

No one decides to be on ten medicines. Lists grow one reasonable step at a time.

A new diagnosis adds a drug. A specialist, focused on their own area, adds another that makes good sense within that area. A hospital stay can add several at once, some meant only for the admission, and they follow the patient home. Over-the-counter products and supplements go uncounted because people do not think of them as medicines. And refills continue on autopilot, month after month, long after anyone remembers why the medicine was started.

Then there is the prescribing cascade. A medicine causes a side effect. The side effect is read as a new symptom, so a second medicine is added to treat it, rather than anyone recognizing the first drug as the cause. A drug that causes swelling in the ankles leads to a water pill; the water pill lowers potassium, so a supplement is added. Each link in that chain can look sensible in isolation.

That is exactly the problem. Not one of these steps is unreasonable, which is why lists drift upward without anyone ever choosing to lengthen them. The growth happens gradually, and gradual growth is easy to miss.

The risks of too many medicines#

More medicines does not automatically mean worse, but the odds shift. A few general risk categories are worth understanding.

• Drug-drug interactions. Two medicines can change how each other works, sometimes amplifying an effect, sometimes blunting it.
• Drug-disease interactions. A medicine that is fine for most people can be a poor fit for someone with a particular condition, worsening it rather than leaving it alone.
• Additive effects. Several medicines that each nudge in the same direction can add up. Two or three that each cause a little drowsiness, or each lower blood pressure a bit, can combine into something the patient feels.
• Pill burden. A complicated schedule is simply harder to follow. Missed or doubled doses become more likely as the list grows.

These are not abstractions. They connect to the outcomes older adults care about most: confusion, dizziness, falls, and avoidable trips to the emergency department or hospital. A fall that fractures a hip can start a long decline, and medication effects are among the causes that can actually be changed.

This guide describes categories and mechanisms, deliberately, and naming no specific drug. The point of a review is not to hand anyone a list of medicines to stop. It is to have the right conversation about the whole list.

Tools clinicians use: the Beers Criteria and structured checks#

Clinicians do not have to rely on memory alone. One widely used tool is the American Geriatrics Society Beers Criteria, an expert-reviewed list of potentially inappropriate medications for adults 65 and older. It is updated on a regular cycle, and the 2023 update is the current version. The list flags medicines that are often best avoided in older adults, or used only with caution, because the balance of risk and benefit tends to tip unfavorably with age.

The framing matters as much as the list. The AGS is explicit that the criteria are meant to support, not replace, shared clinical decision-making. Being on the list does not mean a medicine is forbidden for a given person. It means the medicine deserves a second look and a conversation. For some patients, a flagged drug is still the right choice.

Good clinicians also weigh things a list cannot capture: life expectancy, what the person is trying to achieve, and what matters to them day to day. A medicine that prevents a problem years down the line has a different value for someone focused on comfort now than for someone with a long horizon. Tools like the Beers Criteria are a prompt for that judgment, not a substitute for it.

The periodic medication review: what a good one looks like#

One of the most practical safeguards is unglamorous: sit down, once in a while, and go through everything.

A useful version is the "brown bag" review. The patient brings, in an actual bag if that helps, every product they take. Not just prescriptions, but over-the-counter drugs, vitamins, supplements, creams, inhalers, and eye drops. Eye drops in particular are easy to forget, and they can matter. The goal is to see the true, complete list, which is almost always longer than the one on file.

Then each item gets a few plain questions:

• Why was this started, and is that reason still true?
• Is it still needed?
• Does the benefit still outweigh the risk for this person now?
• Does anything here duplicate another medicine or interact with it?

A primary care clinician can lead this, and a pharmacist is often ideally placed to do it, since medicines are their whole focus. A reasonable rhythm is at least once a year, and again after any hospital stay, emergency visit, or major change in health. Those transitions are precisely when new medicines get added and old ones get muddled, which is why reconciling the list at those moments (medication reconciliation) catches so much.

Deprescribing: reducing medicines safely and on purpose#

When a review finds a medicine that no longer helps, or may be doing harm, the answer is often deprescribing: the planned, supervised reduction or stopping of that medicine. The word can sound alarming. Done properly, it is careful and unhurried.

A few general principles hold. Deprescribing is a shared decision, not something imposed. It is usually done one medicine at a time, so that if something changes, the cause is clear. Many medicines are tapered gradually rather than stopped abruptly, because the body has adjusted to them and needs time to readjust. And it is monitored, watching for the return of the original symptom or for any withdrawal effect, so the plan can be paused or reversed.

What does the evidence say? Read neutrally, it is encouraging but not sweeping. Randomized trials and a systematic review with meta-analysis show that medication burden and potentially inappropriate medications can be reduced without increasing adverse events. Some structured programs have shown this even at fragile moments: the Shed-MEDS trial reduced medications for older adults moving from hospital through post-acute care, and the EMPOWER trial showed that direct patient education could safely reduce certain long-standing prescriptions. At the same time, effects on hard outcomes like falls or mortality are mixed and still being studied, and both observational and trial evidence carry limits. A 2024 review lays out that nuance well.

Put plainly: you can usually lighten the load without trading it for harm, but deprescribing is not a guaranteed shortcut to fewer falls or longer life. That is a reason to do it thoughtfully, with a clinician, and never alone.

Bringing your own list to the table#

Picture your next appointment with one page in hand that lists everything you take, doses included, from your blood pressure pill down to your eye drops and the fish oil you buy yourself. That single page changes the conversation. It lets you and your clinician see the whole picture at once, which is the only way to spot a duplicate or an interaction.

A few concrete habits make it work. Keep that one list current, and update it whenever something changes. Use a single pharmacy where you can, so one system sees your whole profile. Bring the list, or the actual bottles, to every visit. And come ready to ask the three questions that matter for each medicine: Do I still need this? What is it for? What would happen if I stopped it? Name one goal for the visit, and bring a family member or caregiver if a second set of ears would help.

None of this is a decision to change a medicine. It is preparation for a better conversation, and any actual change belongs with your own clinician or pharmacist. The aim is not fewer pills for their own sake. It is a list that still fits the person taking it.